Target
Cyclin-dependent kinase 7
Ligand
BDBM50603992
Substrate
n/a
Meas. Tech.
ChEMBL_2245831 (CHEMBL5160041)
Kd
200±n/a nM
Citation
 Taft, BRYokokawa, FKirrane, TMata, ACHuang, RBlaquiere, NWaldron, GZou, BSimon, OVankadara, SChan, WLDing, MSim, SStraimer, JGuiguemde, ALakshminarayana, SBJain, JPBodenreider, CThompson, CLanshoeft, CShu, WFang, EQumber, JChan, KPei, LChen, YLSchulz, HLim, JAbas, SNAng, XLiu, YAngulo-Barturen, IJiménez-Díaz, MBGamo, FJCrespo-Fernandez, BRosenthal, PJCooper, RATumwebaze, PAguiar, ACCCampo, BCampbell, SWagner, JDiagana, TTSarko, C Discovery and Preclinical Pharmacology of INE963, a Potent and Fast-Acting Blood-Stage Antimalarial with a High Barrier to Resistance and Potential for Single-Dose Cures in Uncomplicated Malaria. J Med Chem 65:3798-3813 (2022) [PubMed] 
Target
Name:
Cyclin-dependent kinase 7
Synonyms:
39 kDa protein kinase | CAK | CAK1 | CDK-activating kinase | CDK-activating kinase 1 (CAK) | CDK7 | CDK7_HUMAN | CDKN7 | Cell division protein kinase 7 | Cyclin-Dependent Kinase 7 (CDK7) | Cyclin-dependent kinase 7 (CDK7/cyclin H) | MO15 | P39 Mo15 | STK1 | TFIIH basal transcription factor complex kinase subunit
Type:
Enzyme Subunit
Mol. Mass.:
39047.01
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
346
Sequence:
MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGGLPKKLIF
  
Inhibitor
Name:
BDBM50603992
Synonyms:
CHEMBL5179988
Type:
Small organic molecule
Emp. Form.:
C14H15F2N5S
Mol. Mass.:
323.364
SMILES:
CC(C)(N)CNc1nn2c(cnc2s1)-c1ccc(F)cc1F
Structure:
Search PDB for entries with ligand similarity: